Pharma news
Americas
Anacor Pharmaceuticals has unsuccessfully challenged the invalidation of four patents covering Kerydin, an antifungal treatment for nails. 1 September 2020
Pharma
The European Commission’s first ever contract to secure a COVID-19 vaccine came into force on August 27, after it signed a deal with pharmaceutical company AstraZeneca. 1 September 2020
Pharma
Genentech and Chugai Pharmaceutical will have to face claims that its haemophilia drug Hemlibra (emicizumab-kxwh) infringed a patent owned by Takeda subsidiary Baxalta. 28 August 2020
Americas
Bristol Myers Squibb has announced a deal to acquire protein engineering company Forbius, including its portfolio of protein inhibitors. 27 August 2020
Americas
Amgen’s subsidiary Immunex has called on the US Court of Appeals for the Federal Circuit to reject Sandoz’s request for an en banc rehearing of a dispute over biologic Enbrel. 27 August 2020
Americas
Swiss-based Ferring Pharmaceuticals has prevailed in a patent dispute with rivals Serenity Pharmaceuticals and Reprise Biopharmaceuticals over a nighttime urination, or nocturia, treatment. 25 August 2020
Pharma
In a boost for generic pharma companies, a U-turn by the EU’s highest court removed protection for repurposed active substances, as Robert Stephen and Gareth Morgan of CMS Cameron McKenna Nabarro Olswang explain. 25 August 2020
Americas
A district judge has given India-based Dr Reddy’s the greenlight to move forward with its antitrust counterclaims against Indivior. 25 August 2020
Pharma
The FTC should avoid reviewing communications between Martin Shkreli and his attorneys, but these are not protected under the Privacy Act, a New York federal judge has ruled. 21 August 2020
Pharma
Sandoz has gathered support for its request for an en banc rehearing of a ruling that blocks it from selling a version of biologic Enbrel until 2029. 20 August 2020